The potential use of maturation in vitro of human oocytes in low responder patients

J Assist Reprod Genet. 2000 May;17(5):239-44. doi: 10.1023/a:1009405730750.

Abstract

Purpose: To assess whether maturation in vitro of human oocytes (MIVHO) could be an alternative treatment in low responders to ovarian stimulation for in vitro fertilization (IVF).

Methods: Prospective case-control study. Spontaneously ovulatory women who volunteered were included in our program of MIVHO at the Instituto Valenciano de Infertilidad. Rates of oocyte retrieval, in vitro maturation, fertilization, and development up to the blastocyst stage were studied.

Results: A significantly increased rate of oocyte retrieval was found when the pickup was performed before follicular selection. No differences were found when MIVHO was used in a low responder patient with an ovarian content of early antral follicles > 5 as compared to normal responders.

Conclusions: MIVHO could be a successful choice in low responder patients with an acceptable number of early antral follicles. Oocyte retrieval should be performed before follicular selection in order to obtain more oocytes.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Case-Control Studies
  • Estrogens / blood
  • Female
  • Fertility
  • Fertilization in Vitro / methods*
  • Follicle Stimulating Hormone / blood
  • Humans
  • Infertility / blood
  • Infertility / therapy*
  • Luteinizing Hormone / blood
  • Male
  • Oocytes / cytology
  • Oocytes / growth & development*
  • Oocytes / metabolism
  • Ovarian Follicle / cytology
  • Ovarian Follicle / growth & development
  • Ovarian Follicle / metabolism
  • Ovulation Induction / methods*
  • Sperm Injections, Intracytoplasmic

Substances

  • Estrogens
  • Luteinizing Hormone
  • Follicle Stimulating Hormone